Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $120754.0.

  • Pharma-Bio Serv's Other Non-Current Assets fell 4647.41% to $120754.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $120754.0, marking a year-over-year decrease of 4647.41%. This contributed to the annual value of $120754.0 for FY2025, which is 4647.41% down from last year.
  • As of Q4 2025, Pharma-Bio Serv's Other Non-Current Assets stood at $120754.0, which was down 4647.41% from $225649.0 recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Other Non-Current Assets high stood at $353407.0 for Q3 2021, and its period low was $111665.0 during Q4 2023.
  • In the last 5 years, Pharma-Bio Serv's Other Non-Current Assets had a median value of $178299.0 in 2023 and averaged $204543.3.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 6314.3% in 2023, then skyrocketed by 10205.51% in 2025.
  • Over the past 5 years, Pharma-Bio Serv's Other Non-Current Assets (Quarter) stood at $353354.0 in 2021, then plummeted by 62.96% to $130874.0 in 2022, then decreased by 14.68% to $111665.0 in 2023, then skyrocketed by 102.03% to $225599.0 in 2024, then tumbled by 46.47% to $120754.0 in 2025.
  • Its last three reported values are $120754.0 in Q4 2025, $225649.0 for Q3 2025, and $225643.0 during Q2 2025.